- Home
- AVIR vs UHG Comparison
AVIR vs UHG Comparison
Compare AVIR & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- UHG
- Stock Information
- Founded
- AVIR 2012
- UHG 2004
- Country
- AVIR United States
- UHG United States
- Employees
- AVIR N/A
- UHG N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- UHG Homebuilding
- Sector
- AVIR Health Care
- UHG Consumer Discretionary
- Exchange
- AVIR Nasdaq
- UHG Nasdaq
- Market Cap
- AVIR 247.5M
- UHG 253.1M
- IPO Year
- AVIR 2020
- UHG N/A
- Fundamental
- Price
- AVIR $3.42
- UHG $4.13
- Analyst Decision
- AVIR Hold
- UHG
- Analyst Count
- AVIR 1
- UHG 0
- Target Price
- AVIR $6.88
- UHG N/A
- AVG Volume (30 Days)
- AVIR 556.5K
- UHG 86.2K
- Earning Date
- AVIR 02-26-2025
- UHG 11-08-2024
- Dividend Yield
- AVIR N/A
- UHG N/A
- EPS Growth
- AVIR N/A
- UHG N/A
- EPS
- AVIR N/A
- UHG N/A
- Revenue
- AVIR N/A
- UHG $445,729,916.00
- Revenue This Year
- AVIR N/A
- UHG N/A
- Revenue Next Year
- AVIR N/A
- UHG N/A
- P/E Ratio
- AVIR N/A
- UHG N/A
- Revenue Growth
- AVIR N/A
- UHG 6.19
- 52 Week Low
- AVIR $2.75
- UHG $4.01
- 52 Week High
- AVIR $4.60
- UHG $9.13
- Technical
- Relative Strength Index (RSI)
- AVIR 62.36
- UHG 34.32
- Support Level
- AVIR $3.19
- UHG $4.11
- Resistance Level
- AVIR $3.32
- UHG $4.57
- Average True Range (ATR)
- AVIR 0.13
- UHG 0.28
- MACD
- AVIR 0.04
- UHG 0.02
- Stochastic Oscillator
- AVIR 82.58
- UHG 15.33
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments.